Heek G Jan Van's Net Worth
$28.6 Million
Who is Heek G Jan Van?
Heek G Jan Van has an estimated net worth of $28.6 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, GENZYME CORP, Minerva Neurosciences, Inc., and VIACELL INC.
SEC CIK
Heek G Jan Van's CIK is 0001021040
Past Insider Trading and Trends
2003 was Heek G Jan Van's most active year for acquiring shares with 53 total transactions. Heek G Jan Van's most active month to acquire stocks was the month of September. 2003 was Heek G Jan Van's most active year for disposing of shares, totalling 102 transactions. Heek G Jan Van's most active month to dispose stocks was the month of September. 2003 saw Heek G Jan Van paying a total of $28,467,543.93 for 1,122,096 shares, this is the most they've acquired in one year. In 2003 Heek G Jan Van cashed out on 2,186,523 shares for a total of $53,224,003.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| -43.78% | -11.04K |
$12.24 | -$3,214,252.98 | 14.17K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +7.48% | 1.75K |
$5.59 | $9,810.45 | 25.2K |
Jul 9 - Jul 10
| |||
Form 4
| +6.01% | 1.33K |
$7.38 | $9,808.02 | 23.45K |
Apr 10
| |||
Form 4
| +4.48% | 948 |
$8.37 | $7,934.76 | 22.12K |
Jan 10
| |||
Form 4
| +3.46% | 708 |
$11.20 | $7,929.60 | 21.17K |
Oct 10
| |||
Form 4
| +2.77% | 551 |
$14.40 | $7,934.40 | 20.46K |
Jul 10
| |||
Form 4
| +4.45% | 848 |
$9.35 | $7,928.80 | 19.91K |
Apr 10
| |||
Form 4
| +4.92% | 894 |
$7.06 | $6,311.64 | 19.06K |
Jan 10
| |||
Form 4
| +3.80% | 666 |
$9.47 | $6,307.02 | 18.17K |
Oct 11
| |||
Form 4
| +2.61% | 445 |
$14.18 | $6,310.10 | 17.5K |
Jul 11
| |||
Form 4
| +4.55% | 742 |
$8.50 | $6,307.00 | 17.06K |
Apr 11
| |||
Form 4
|
—
|
0
|
$8.81 | -$466,479.00 | 16.32K |
Apr 25
| |||
Form 4/A
| -15.53% | -3.00K |
$1.03 | -$3,090.00 | 16.32K |
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$8.77 | -$46,440.00 | 19.32K |
Scheduled
|
Apr 18
| ||
Form 4
| +3.68% | 685 |
—
|
—
| 19.32K |
Feb 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENZYME CORP No price found
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +241.28% | 19.22K |
$38.87 | -$6,194,835.93 | 27.19K |
Oct 17
| |||
Form 4
|
—
|
0
|
$46.80 | -$12,120.05 | 24.37K |
Dec 17
| |||
Form 4/A
| +203.59% | 19.22K |
$38.87 | -$6,194,835.93 | 28.66K |
Oct 17
| |||
Form 4
| +203.59% | 19.22K |
$39.09 | -$6,239,331.93 | 28.66K |
Oct 17
| |||
Form 4
|
—
|
0
|
$26.84 | -$978,500.00 | 3.52K |
Scheduled
|
Oct 1
| ||
Form 4/A
|
—
|
0
|
$27.26 | -$999,445.15 | 3.52K |
Scheduled
|
Sep 2
| ||
Form 4/A
|
—
|
0
|
$27.26 | -$999,445.15 | 3.52K |
Scheduled
|
Sep 2
| ||
Form 4/A
|
—
|
0
|
$28.66 | -$1,069,250.00 | 3.51K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$27.26 | -$999,445.15 | 3.51K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$28.66 | -$1,069,250.00 | 3.51K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $10.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +52.50% | 7K |
$2.97 | $20,790.00 | 20.33K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +300.03% | 10K |
$5.37 | $53,700.00 | 13.33K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
∞
| 3.33K |
$6.00 | $19,998.00 | 3.33K |
Jun 30 - Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIACELL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||